Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Boehringer Ingelheim
McKinsey
Baxter
Colorcon

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Deoxythymidine

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Deoxythymidine?

Deoxythymidine is an investigational drug.

There have been 8 clinical trials for Deoxythymidine. The most recent clinical trial was a Phase 2 trial.

The most common disease conditions in clinical trials are HIV Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Bristol-Myers Squibb, and Vall d'Hebron Research Institute.

Recent Clinical Trials for Deoxythymidine
TitleSponsorPhase
An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2Modis Therapeutics, Inc.Phase 2
Treatment of TK2 Deficiency With Thymidine and DeoxycytidineCentro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), SpainPhase 1/Phase 2
Treatment of TK2 Deficiency With Thymidine and DeoxycytidineHospital Universitario 12 de OctubrePhase 1/Phase 2

See all Deoxythymidine clinical trials

Clinical Trial Summary for Deoxythymidine

Top disease conditions for Deoxythymidine
Top clinical trial sponsors for Deoxythymidine

See all Deoxythymidine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Mallinckrodt
Dow
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.